Go
Sort by:
titlesubmit dateissue date
Order:
ascendingdescending
Results:
51020406080100
Update
Now showing items 1-2 of 2
Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth
journal article
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.